- Home
- FUSB vs OKYO Comparison
FUSB vs OKYO Comparison
Compare FUSB & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUSB | OKYO |
|---|---|---|
| Founded | 1952 | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.8M | 79.7M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | FUSB | OKYO |
|---|---|---|
| Price | $14.03 | $1.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 11.7K | ★ 154.8K |
| Earning Date | 01-26-2026 | 07-18-2025 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.93 | N/A |
| Revenue | ★ $36,068,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.26 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.30 | $0.90 |
| 52 Week High | $14.79 | $3.35 |
Technical Indicators
Market Signals| Indicator | FUSB | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 61.88 | 46.23 |
| Support Level | $13.41 | $1.90 |
| Resistance Level | $14.79 | $2.16 |
| Average True Range (ATR) | 0.29 | 0.22 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 45.32 | 34.94 |
Price Performance
Historical ComparisonAbout FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.